Survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis have an increased risk of cardiovascular mortality in the year after diagnosis.

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...